Brii Biosciences Competitors and Similar CompaniesClear all

Brii Biosciences's competitors and similar companies include Benchmark Research, Molecular Partners and Y-mAbs Therapeutics.

	Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.	Benchmark Research Benchmark Research is a clinical research firm that conducts investigational studies for the development of vaccines and medicines.	Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases.	Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Founding Date	Founding Date 2018	Founding Date 1997	Founding Date 2004	Founding Date 2014
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma therapy	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma therapy	Tags Healthcare biotech clinical research drug development pharma therapy
Locations	Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US	Locations Austin, US HQ Colton, US Fort Worth, US Metairie, US Sacramento, US San Angelo, US San Francisco, US see more	Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US	Locations New York, US HQ Copenhagen, DK Nutley, US
Employees	Employees 8510% decrease	Employees 719% decrease	Employees 158	Employees 3239% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $87.7m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $15m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $72.7m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income (CHF61.7m) (FY, 2025)	Net income ($29.7m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 415m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 80m